Search results
-
Analyst consensus
Consensus collated from estimates submitted by side-sell analysts on Croda International Plc.
-
Our Board activity in 2025
An update from Croda’s 2025 Annual Report on Board governance and culture, highlighting leadership, accountability and the values guiding long-term sustainable growth.
-
Life Sciences business review - rebalancing Pharma and driving differentiation in Agriculture
Discover how Life Sciences is rebalancing Pharma and driving differentiation in Agriculture. Exploring innovation, market trends, and strategic growth driving performance in this year’s annual report business review.
-
CrodaTherm helps COVID19 nurses in The Netherlands
CrodaTherm™ helps reduce heat strain experienced by COVID-19 nurses in The Netherlands
-
Croda supports Kayapo indigenous people during COVID19
We are continuing to support local communities during the COVID-19 pandemic by providing soap bars to indigenous communities in Brazil
-
Sustainability without compromise ChromaPur
Small, manufactured plastic particles, known as microbeads, are used in a wide range of cosmetic and personal care products, with research suggesting that 87% of products from the ten best-selling cosmetics brands contain these microplastics.
-
Leveraging Group-wide capabilities to accelerate the development of natural active ingredients
The move in cosmetics towards replacing synthetic ingredients with sustainable alternatives is increasing demand for naturally sourced actives.
-
Croda and Anome Collaboration Promises a Positive Difference in Beauty Effects
We are very proud to announce a new collaborative partnership with Anomera, an award-winning innovator in green chemistry, materials science and sustainable manufacturing.
-
International chemicals leader Croda expands presence at Techspace One
Croda has expanded its presence at Sci-Tech Daresbury in line with plans to scale up its biotechnology capability.
-
Contract for innovative delivery system for COVID19 vaccine
We have recently entered into an agreement with Pfizer Inc. to supply novel excipients used in the manufacture of a COVID-19 vaccine candidate.
-
Croda invests in biopharma innovation with expanded Super Refined™ facility in Leek, UK
25 September 2025: Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and solutions that improve lives, continues to invest in the evolving world of biopharmaceutical manufacturing where consistency and purity in ingredients are critical.
-
Croda Executive Committee walk Yorkshire Three Peaks
Our Executive Committee has pledged to raise vital funds to support COVID-19 relief in India.
-
Strong strategic delivery built on resilient financial performance
Croda 2020 full-year results, strong strategic delivery built on resilient financial performance
-
Supporting local school children during lockdown
We are supporting school children in the UK by gifting our pre-owned laptops and tablets to pupils having lessons at home
-
Life Sciences sustainability review
Sustainability is embedded in our business strategy, shaping innovation and meeting customer expectations. In Life Sciences, it drives impact, performance and long-term value.
-
100 years of smart science: Celebrating Croda's centenary at our headquarters
Join us as we celebrate Croda’s 100-year journey from a small family firm in Yorkshire to a global leader in sustainable innovation. Discover the science, stories, and people behind a century of improving lives.
-
2025 Annual Report
Croda’s 2025 Annual Report allows you to explore our financial performance, strategic progress, sustainability highlights, and innovation driving long-term growth.
-
Why invest in Croda?
Discover why investing in Croda offers long-term growth, innovation-led performance, and sustainable value across global specialty chemicals markets.
-
Our business model
Our business model is designed to create long-term, sustainable value.
-
A day in the life of our IT team
Welcome to a behind-the-scenes look at the world of Information Technology (IT) at Croda.